COVID-19 continues and catapults the number of telehealth applications to unimagined heights. In 2019, the use of Remote Patient Monitoring Services in the USA was 11% – by 2020, it reaches 46% of the population who make their doctor visits in this way.
In the course of the corona pandemic, practices and hospitals reached the limits of their capacities. Countless appointments had to be canceled and medical advice, let alone treatment, became increasingly difficult to access.
One niche has been hugely popular in this emergency and will continue to focus on attention until an effective vaccine promises to improve the situation. Remote Patient Monitoring in Houston has made great progress due to such circumstances and advances in today’s digital world.
As much potential as this digital alternative to physical doctor visits may hold, there are still hurdles in this area. In particular, security, integration into the workflow, effectiveness, and the prospect of reimbursement are the major concerns.
Experts are currently looking outside the box of COVID-19 and see opportunities that promise a lot in a future scenario of a return to normal. Besides, understanding that advantages of remote patient monitoring have provided an enhanced level of patient comfort level.
Remote Patient Monitoring in Houston, USA, could guarantee basic medical care, especially in areas with inadequate access to medical services. Still, it could also increase patient comfort and improve the outcome of illnesses.
To facilitate the advantages of remote patient monitoring, five models have been developed for the practical implementation and benefits of remote patient monitoring of this project:
Less serious cases that normally end in the emergency room represent the majority of Telehealth users and thus offer the ideal application area to relieve hospitals.
This model can be used in cases in which physical treatment is not required. This mainly includes basic care and behavioral medicine, but also cardiac rehabilitation.
A mixture of remote patient monitoring services and personal support from a permanent team, coupled with comfort, accessibility, and continuity, forms the concept’s core. It is also designed to facilitate the treatment of chronic conditions by enabling remote patient monitoring, virtual therapeutics, and digital coaching.
In this way, virtual medical consultations are to be coupled with visits to “worksite” clinics. Tests and immunizations can be carried out there.
Virtual visits, remote patient monitoring, and digital ways to encourage patient engagement in the recovery process are at the fore.
Direct services such as wound care, however, still have to take place on-site.
In this model, patients are supposed to take their medication, which is delivered to their home, self-administered, and experts monitor employees during home visits.
We recently asked our readers to take part in a short survey on the subject of COVID-19 and pharmaceutical marketing. We have now summarized the results for you.
When the COVID-19 infections increased in this country in March of this year (2020) and exit restrictions came into effect within a few days, and the company switched to the home office, the world of work also changed permanently. In the pharmaceutical industry, this means, above all, that the sales force cannot visit doctors as usual until further notice. This is exactly where people get maximum advantages of remote patient monitoring in Houston. However, it posed major challenges for many pharmaceutical companies. Above all, those companies that were previously rather poorly positioned digitally are now looking for quick and simple solutions in order to be able to continue to reach their doctors. On the other hand, there were several benefits of remote patient monitoring services for the patients.
We have taken these changes as an opportunity to ask our readers how they deal with this situation in their everyday work and which areas of your job are particularly affected. Using an online questionnaire, 50 representatives from the industry gave us anonymous insight into current challenges and internal structures.
82% of the respondents are of the opinion that COVID-19 will have a very strong, lasting effect on the pharmaceutical industry. It is already becoming noticeable that there is a will to innovate in some companies when a rethink is inevitable. Within a few days, large webinars are implemented, or innovative projects are implemented by field staff.
Part of the survey relates to changes in the internal budget. A full 74% of those surveyed stated that there was a very clear (34%) or clear (40%) budget shift in the direction of digital channels.
A change that is only logical in the current situation. If personal contact is lost, (new) digital channels must be consulted in order to continue to bring your own content to the target group. This is also the primary goal of the digital marketing activities of our respondents, followed by positioning as an innovative, creative company.